Subscribe to our Newsletters !!

    Bioscience

    Let us know some facts about Coronavirus

    It was post-dinner time on Saturday 4th April 2020; the 12th evening of lock-down in India. Mr.Madhav was sitting in front of his laptop eagerly waiting for the bell of 10 pm on Web meeting. He and his close friends Kiran, Avinash, Santosh, Suhas, Mahesh, Rajan, Seema, Kavya, Vidya, Geetanjali and Namrata from different places

    XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation® Technology

    SAN DIEGO, U.S.A., and FREISING, Germany, October 15, 2020 – Life Science Newswire – Antlia Bioscience, Inc., a privately owned biopharmaceutical company located in San Diego, California, and XL-protein GmbH, a privately owned biopharmaceutical company located in Germany, are pleased to announce a strategic slliance using XL-protein’s proprietary PASylation® technology for plasma half-life extension to